UNSPSC 51283101: Anidulafungin

This classification denotes an antifungal agent with the molecular formula C58H73N7O17, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9HLM53094I, chemically known as echinocandin b, 1-((4r,5r)-4,5-dihydroxy-n2-((4-(pentyloxy)(1,1:4,1-terphenyl)-4-yl)carbonyl)-l-ornithine) but generally known as anidulafungin, which bears US NIH Compound Identifier 166548. European Medicines Agency schedules Anidulafungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22240.

UNSPSC 51283101 Anidulafungin is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though recent activity under this code shows little alignment with anidulafungin specifically. State and local buyers are soliciting generic pharmaceuticals, over-the-counter products, and emergency medical supplies through this category, as evidenced by recent procurements from health departments, fire departments, and cooperative purchasing consortia. Issuing bodies include state health and human services departments (Texas Health and Human Services Commission), county health systems (Seminole County, Florida), municipal fire departments (Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The mix reflects how state and local governments consolidate pharmaceutical sourcing across clinical, emergency response, and community health programs, often through cooperative vehicles that serve multiple jurisdictions simultaneously.

Recent activity concentrates in Florida, Texas, and Minnesota. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies for the Tampa Fire Department Rescue Division, valued at $700,000, with a sheltered-market designation for certified Small Local Business Enterprises and a 5 percent SLBE bid discount not to exceed $10,000; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and GPO channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with evaluations weighted primarily on price competitiveness (75 percent) and contract terms effective July 1, 2026.